Washington Post August 3, 2021
Alexandra Ellerbeck

with Paige Winfield Cunningham

The U.S. has gotten a crash course over the past 18 months in just how important the biomedical research pipeline can be, as scientists turned years of basic science research into highly effective vaccines against the coronavirus in record-time.

Now, lawmakers say the U.S. is due for big investments to its biomedical infrastructure.

Reps. Diana DeGette (D-Colo.) and Fred Upton (R-Mich.) are pushing a bill that would build on the 21st Century Cures Act, a major overhaul in biomedical research passed in 2016 designed to speed up the pipeline for medical innovation.

DeGette and Upton have dubbed their new...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Cures Act, Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
What Washington wants in Cures 2.0
How ONC Can Strengthen Its HTI-1 Rule To Ensure Transparency, Fairness, And Equity In AI
Providers Take Note: The Common Agreement Version 2.0 Released
Advancing Nationwide, Trusted Health Information Networks
Cures Act tied to quicker release, access of imaging reports

Share This Article